Drug-drug interaction prediction on TWOSIDES
0.9902AUROCMolTC
Evaluation results
| Method | Links | ||||
|---|---|---|---|---|---|
| MolTC2024.02 | 0.9902 | 0.9842 | — | — | |
| MolT52024.02 | 0.94 | 0.9273 | — | — | |
| MolCA2024.02 | 0.9368 | 0.9007 | — | — | |
| ClinicalFocalYear=2026, Architecture=Focal Loss + Binary Classification2026.07 | 0.914 | 0.892 | 0.86 | 89.4 | |
| Chem T52024.02 | 0.8952 | 0.8443 | — | — | |
| SkipGNNYear=2020, Architecture=Skip Graph MPNN2026.07 | 0.892 | 0.853 | 0.874 | 83.4 | |
| MHCADDIEvaluation protocol=stratified 10-fold cross-validation, Attention heads=8, Propagation blocks=32019.05 | 0.882 | — | — | — | |
| Galactica2024.02 | 0.8799 | 0.8201 | — | — | |
| DecagonEvaluation protocol=stratified 10-fold cross-validation2019.05 | 0.872 | — | — | — | |
| CASTERYear=2020, Architecture=Substructure Encoder-Decoder2026.07 | 0.856 | 0.822 | 0.831 | 79.8 | |
| BioBERTYear=2020, Architecture=BERT Embedding2026.07 | 0.841 | 0.802 | 0.812 | 78.5 | |
| MHCADDI-MLEvaluation protocol=stratified 10-fold cross-validation, Classification type=multi-label classification, Attention heads=8, Propagation blocks=32019.05 | 0.819 | — | — | — | |
| Concatenated featuresEvaluation protocol=stratified 10-fold cross-validation2019.05 | 0.793 | — | — | — | |
| KG-DDIYear=2019, Architecture=Knowledge Graph Conv-LSTM2026.07 | 0.787 | 0.787 | 0.721 | 78.5 | |
| DeepWalkEvaluation protocol=stratified 10-fold cross-validation2019.05 | 0.761 | — | — | — | |
| Drug-FingerprintsEvaluation protocol=stratified 10-fold cross-validation, Classification type=binary classification2019.05 | 0.744 | — | — | — | |
| DEDICOMEvaluation protocol=stratified 10-fold cross-validation2019.05 | 0.705 | — | — | — | |
| RESCALEvaluation protocol=stratified 10-fold cross-validation2019.05 | 0.693 | — | — | — |